Kinga Borsos, PharmD, MBA, MS

Value & Access and HEOR Leader
Boehringer Ingelheim Pharmaceuticals, Inc.

Poster(s):

• (269) Healthcare resource utilization and costs of schizophrenia among Medicaid beneficiaries
  Wednesday, October 29, 2025